Adjuvant Data Changing Clinical Practice Moving into Anti-PD-1 monotherapy, and BRAF
Ahmad Tarhini, MD, PhD, Cleveland Clinic Main Campus, talks about Adjuvant Data Changing Clinical Practice Moving into Anti-PD-1 monotherapy, and BRAF at Annual Meeting 2018
138 Views
5 years Ago
Melanoma and Skin
KEYNOTE-716 Unveiled: Advancing Melanoma Cancer Treatment
32 Views
Retifanlimab safety in solid tumors INCAGN02385, & INCAGN02390
20 Views
Melanoma Cancer Adjuvant Therapy: Final Analysis Phase 3 KEYNOTE-716
76 Views
The Best Cutaneous Treatments from ASCO 2023
105 Views
![IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [22]](https://oncologytubecom.cdn.ypt.me/videos/video_221121150352_vadef/video_221121150352_vadef_thumbsV2_jpg.webp?cache=1683201732_1691418989 "IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [22]")
IDE196 Solid Tumors GNAQ/11 Mutations or PRKC Fusions [22]
121 Views
![SWOG S1801 Trial: Pembro After or Before Surgery? [2022]](https://oncologytubecom.cdn.ypt.me/videos/v_220930141843_v1d46/v_220930141843_v1d46_thumbsV2_jpg.webp?cache=1664996129_1691418989 "SWOG S1801 Trial: Pembro After or Before Surgery? [2022]")
SWOG S1801 Trial: Pembro After or Before Surgery? [2022]
371 Views
![M14TIL Trial: TIL Compared to Std. Ipilimumab [2022]](https://oncologytubecom.cdn.ypt.me/videos/v_220930141216_v1027/v_220930141216_v1027_thumbsV2_jpg.webp?cache=1664994746_1691418989 "M14TIL Trial: TIL Compared to Std. Ipilimumab [2022]")
M14TIL Trial: TIL Compared to Std. Ipilimumab [2022]
62 Views
Hypofractionated radiotherapy for Basal Cell Carcinoma
ASCO 2022 Melanoma Cancer Question & Answer
ASCO 2022 Melanoma In-Depth Slides: MOASC Spotlight
ASCO 2022 Melanoma Overview: MOASC Spotlight
Audio: MASTERKEY-115: A Complete (But Concise) Update for Melanoma Treatment - Brian Gastman, MD @BrianGastmanMD @Gas...
12 Views